Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,252 | 519 | 89.4% |
| Travel and Lodging | $823.31 | 1 | 8.0% |
| Education | $269.60 | 27 | 2.6% |
| Gift | $5.81 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,184 | 123 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,110 | 77 | $0 (2024) |
| Janssen Biotech, Inc. | $977.83 | 59 | $0 (2024) |
| Apollo Endosurgery US Inc | $850.60 | 2 | $0 (2017) |
| Romark Laboratories, LC | $640.85 | 33 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $592.37 | 34 | $0 (2024) |
| Braintree Laboratories, Inc. | $337.23 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $314.44 | 18 | $0 (2023) |
| Ardelyx, Inc. | $263.88 | 15 | $0 (2024) |
| Daiichi Sankyo Inc. | $221.58 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,763 | 93 | ABBVIE INC. ($439.73) |
| 2023 | $1,107 | 59 | ABBVIE INC. ($196.70) |
| 2022 | $818.45 | 49 | ABBVIE INC. ($276.47) |
| 2021 | $1,445 | 91 | AbbVie Inc. ($599.95) |
| 2020 | $856.06 | 53 | Romark Laboratories, LC ($228.93) |
| 2019 | $1,135 | 79 | Romark Laboratories, LC ($252.01) |
| 2018 | $1,248 | 62 | AbbVie, Inc. ($298.84) |
| 2017 | $1,979 | 62 | Apollo Endosurgery US Inc ($850.60) |
All Payment Transactions
548 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: LIVER DISEASE | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.84 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 237 | 274 | $132,494 | $29,920 |
| 2022 | 9 | 237 | 289 | $104,092 | $27,009 |
| 2021 | 14 | 325 | 364 | $132,082 | $34,719 |
| 2020 | 9 | 227 | 243 | $83,943 | $22,963 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 85 | $26,350 | $8,143 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $20,000 | $5,365 | 26.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 22 | 22 | $15,950 | $3,872 | 24.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 31 | 33 | $20,295 | $3,091 | 15.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 15 | 15 | $15,420 | $2,950 | 19.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $14,364 | $2,524 | 17.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $8,700 | $1,657 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 27 | $8,235 | $1,482 | 18.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,180 | $835.25 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 81 | $20,265 | $5,523 | 27.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 27 | 27 | $20,350 | $5,036 | 24.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $11,220 | $3,162 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $9,220 | $3,114 | 33.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 27 | $16,605 | $3,021 | 18.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 24 | $7,584 | $2,605 | 34.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 11 | 11 | $11,308 | $2,211 | 19.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 28 | $5,320 | $1,601 | 30.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 18 | $2,220 | $736.72 | 33.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 70 | $8,610 | $4,595 | 53.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 21 | 21 | $21,588 | $4,238 | 19.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $9,500 | $3,736 | 39.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 30 | 31 | $9,796 | $3,355 | 34.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 27 | 28 | $17,220 | $2,757 | 16.0% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2021 | 17 | 17 | $18,037 | $2,743 | 15.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 14 | 15 | $10,875 | $2,710 | 24.9% |
About Dr. Eric High, M.D
Dr. Eric High, M.D is a Gastroenterology healthcare provider based in Decatur, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730184284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric High, M.D has received a total of $10,351 in payments from pharmaceutical and medical device companies, with $1,763 received in 2024. These payments were reported across 548 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($9,252).
As a Medicare-enrolled provider, High has provided services to 1,026 Medicare beneficiaries, totaling 1,170 services with total Medicare billing of $114,612. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Decatur, GA
- Active Since 06/20/2005
- Last Updated 06/26/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730184284
Products in Payments
- XIFAXAN (Drug) $908.48
- Orbera (Device) $823.31
- STELARA (Biological) $747.46
- LINZESS (Drug) $437.24
- ENTYVIO (Biological) $379.87
- HUMIRA (Biological) $313.02
- MAVYRET (Drug) $295.26
- Humira (Biological) $283.90
- DIFICID (Drug) $269.40
- IBSRELA (Drug) $263.88
- REMICADE (Biological) $261.49
- Alinia (Drug) $252.01
- DUPIXENT (Biological) $246.83
- RINVOQ (Biological) $230.75
- ALINIA (Drug) $228.93
- Creon (Drug) $223.74
- SUPREP BOWEL PREP (Drug) $216.43
- GATTEX (Drug) $205.44
- SKYRIZI (Biological) $198.70
- CREON (Drug) $183.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Decatur
Dr. Shirley Harris, M.d, M.D
Gastroenterology — Payments: $14,948
Muhammad Asim, Md, MD
Gastroenterology — Payments: $14,649
Dr. Kavitha Gopal, M.d, M.D
Gastroenterology — Payments: $10,819
Andrew Simpson, Md, MD
Gastroenterology — Payments: $10,335
Mark Stern, M.d, M.D
Gastroenterology — Payments: $9,677
Paresh Kamat, Md, MD
Gastroenterology — Payments: $8,193